Navigation Links
Pharmasset to Webcast an Investor Event from the AASLD Meeting
Date:11/1/2009

PRINCETON, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) today announced that it will webcast an investor event from the American Association for the Study of Liver Diseases (AASLD) on Monday, November 2, 2009 starting at 7:00pm ET. During this webcast, management will review Pharmasset's progress on the programs that are the subject of presentations at AASLD.

To access a simultaneous webcast of this event via the internet, log on to the "Events & Presentations" section of the Investor Center on Pharmasset's website at http://investor.pharmasset.com/events.cfm . Please connect to the website at least ten minutes prior to the start of the presentation to ensure adequate time for a reliable connection and any software download that may be necessary for the webcast. The following abstracts are available on the AASLD website (AASLD.org).

PSI-7851

Late Breaker Abstract 17

"Antiviral Activity, Pharmacokinetics, Safety, and Tolerability of PSI-7851, a Novel Nucleotide Polymerase Inhibitor for HCV, Following Single and 3 Day Multiple Ascending Oral Doses in Healthy Volunteers and Patients with Chronic HCV Infection" will be presented in a late breaker poster session on Monday November 2nd at 8am ET. Authors of the study are M. Rodriguez-Torres; E. Lawitz; S. Flach; J. M. Denning; E. Albanis; W. Symonds; M. M. Berrey.

RG7128/INFORM-1

Abstract 1585

"Combination Therapy with Nucleoside Polymerase R7128 and Protease R7227/ITMN-191 Inhibitors in Genotype 1 HCV Infected Patients: Interim Resistance Analysis of INFORM-1 Cohorts" will be presented in a poster session on Tuesday November 3rd at 8am ET. Authors of the study are A
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
3. Pharmasset Accesses up to $30 Million of Working Capital
4. Pharmasset to Present at Three Investor Conferences in November 2007
5. Pharmasset Appoints Michael Rogers as Chief Development Officer
6. Pharmasset Reports Fiscal Year End 2007 Financial Results
7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
9. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
10. Pharmasset Appoints Herbert J. Conrad as a Director
11. Pharmasset Receives $10 Million of Working Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... 15 On January 20th, 2010, the ... Medical Publication Professionals (ISMPP) will be held at ... More than 100 attendees are expected at this ... professionals, editors, publishers, medical writers and medical agencies ... and the impact of guidelines and regulations such ...
(Date:12/15/2009)... , - 45 Patients ... of,Cardiopoietic Cells to Restore Cardiac Function ,, ... biotechnology company specialising,in cell-based therapies for the treatment ... two months ahead of schedule,enrolment in the first ... C-Cure, a,unique stem cell therapy for heart failure. ...
(Date:12/14/2009)... BOULDER, Colo. and THOUSAND OAKS, Calif., Dec. 14 ... ) and Amgen Inc.(Nasdaq: AMGN ) today ... Amgen exclusive worldwide rights to Array,s small-molecule glucokinase ... a Phase 1 clinical trial in patients with ... terms of the agreement, Array will receive an ...
Breaking Biology Technology:The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... step towards improving the design of future catalysts ... devices, researchers with the U.S. Department of Energys ... University of California (UC) at Berkeley, have successfully ... of gas-phase reactions on the microscale. , Under ...
... has published,"Thought Leader Insight & Analysis: Alzheimer,s Disease," ... biotech companies with a,stake in the market for ... "Given the size of this patient population and ... it is not surprising to see the,large number ...
... Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTAX: CTIC) announced ... proposal amending and restating the,Company,s articles of incorporation to ... 210 million and to increase the number of,authorized shares ... Louis A. Bianco, Chief Financial Officer at CTI, ...
Other Biology Technology:Berkeley scientists bring MRI/NMR to microreactors 2Berkeley scientists bring MRI/NMR to microreactors 3Berkeley scientists bring MRI/NMR to microreactors 4Berkeley scientists bring MRI/NMR to microreactors 5New Report Tackles the Changing Landscape for Alzheimer's Diagnostics and Treatments 2Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders 2
(Date:12/16/2009)... -- National Instruments (Nasdaq: NATI ), ... and DENSO Robotics, a leader and pioneer ... announced their collaboration to integrate NI measurement ... The collaboration increases productivity and performance in ... In today,s trend toward high-mix, low-volume manufacturing, ...
(Date:12/16/2009)... CHURCH, Va., Dec. 9 CSC ... that the American Association for Laboratory Accreditation ... Commission (ISO/IEC) 17025:2005 accreditation to the company,s ... CSC Identity Labs located in Fairmont, W.Va. ... test laboratory in the world to achieve ...
(Date:12/15/2009)... -- The 2009 Frost & Sullivan European ... to Sagem Securite (Safran Group) for its ... recognises the company,s expertise in advanced biometric ... novel, value-added products to end users. ... "Sagem Securite has been involved in delivering ...
Breaking Biology News(10 mins):National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes 56938 1Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes 56938 2Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 1Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 2Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 3When proteins change partners 9884 1When proteins change partners 9884 2
... fish eater, it,s likely that the salmon you had for dinner ... a mesh cage submerged in the open water of oceans or ... to a growing world population, now supplies, by some estimates, 30 ... species of finfish and shellfish are now grown in farms., Intuitively, ...
... affects how people behave as well as how their brains ... research, presented Sunday at a symposium, "Social Emotion and the ... the Advancement of Science, is the first to use fMRI ... loneliness) and activity in the brain. Combining fMRI scans with ...
... Farmers across the tropics might raze forests to plant ... a postdoctoral researcher at Stanford,s Woods Institute for the ... biofuels produced in the tropics, chances will be good ... tanks," she warned., Policies favoring biofuel crop production may ...
Other Biology News:When fish farms are built along the coast, where does the waste go? 2Researchers shed new light on connection between brain and loneliness 2Researchers shed new light on connection between brain and loneliness 3Biofuels boom could fuel rainforest destruction, Stanford researcher warns 2Biofuels boom could fuel rainforest destruction, Stanford researcher warns 3Biofuels boom could fuel rainforest destruction, Stanford researcher warns 4Biofuels boom could fuel rainforest destruction, Stanford researcher warns 5
... to siRNA library screening, optimal ... identified and verified for each ... CellReady siRNA Transfection Optimization Kit, ... optimizing transfection conditions in 96 ...
Applications: Western blotting ...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, Molecular Biology Grade...
Ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid...
Biology Products: